Earnings Conference Call to be Held on November 11, 2008 at 5:00 am (Pacific) / 8:00 am (Eastern) / 9:00 pm (Beijing/Hong Kong)
SHENYANG, China, Oct. 16 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited financial results for the third quarter ended September 30, 2008 after the US market closes on Monday, November 10, 2008.
The earnings release will be available on the investor relations page of its website at: http://www.3sbio.com/en/News/xShowInfo_nnnn1.aspx?ID=129 .
Following the earnings announcement, 3SBio Inc. senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 9:00 pm (Beijing/Hong Kong) on Tuesday, November 11, 2008 to discuss its 2008 third quarter financial results and recent business activity. The conference call may be accessed by calling (US) +1 480-629-1990 / (UK) +44 20-8515-2302 / (HK) +852 3009-5027. A telephone replay will be available shortly after the call until November 25, 2008 at (US) +1 303-590-3030 / (UK) +44 207-154-2833, Passcode: 3932898#; and (HK) +852 2287-4304, Passcode: 133110#.
A live webcast of the conference call and replay will be available on the investor relations page of 3SBio's website at: http://www.3sbio.com/en/News/xShowInfo_nnnn1.aspx?ID=129 .
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at: http://www.3sbio.com .
For more information, please contact:
Investor Contact:
Kevin Teo, CFO
3SBio Inc.
Tel: +86-24-2581-1820
Investor Relations (US):
Mahmoud Siddig
Taylor Rafferty
Tel: +1-212-889-4350
Investor Relations (HK):
Ruby Yim
Taylor Rafferty
Tel: +852-3196-3712
Media Contact:
Jason Marshall
Taylor Rafferty
Tel: +1-212-889-4350
SOURCE 3SBio Inc.
International News / Press Release source: PR Newswire
Copyright PR Newswire. All Rights Reserved.